Back to Search

The Ki67 Marker in Salivary Gland Tumors.

AUTHOR Garcia, Pedro Emilio; Samar, Mar┬Ła Elena; Avila, Rodolfo Esteban
PUBLISHER Our Knowledge Publishing (08/30/2021)
PRODUCT TYPE Paperback (Paperback)

Description
Salivary gland tumors are an infrequent and heterogeneous group of neoplasms, which implies difficulties in both diagnosis and prognosis of this pathology. Ki67 is a marker that is expressed in dividing cells and has been found to be associated with increased aggressiveness in different types of tumors. The aim of this work was to demonstrate the importance of Ki67 as a prognostic factor in patients with salivary gland tumors treated with radiotherapy.Patients with localized salivary gland tumors treated with radiotherapy were evaluated; Ki67 labeling was performed by immunohistochemistry; it was stratified into high (greater than 20%), low (between 1% and 20%) and negative (less than or equal to 1%); and the expression was related to the percentage of recurrences, distant metastases and deaths due to disease.Overall survival, recurrence-free survival, metastasis-free survival and cause-specific survival were calculated. In conclusion, high Ki67 expression was associated with a higher number of metastases and deaths from disease, with worse survival in patients with salivary gland tumors.
Show More
Product Format
Product Details
ISBN-13: 9786204047638
ISBN-10: 6204047639
Binding: Paperback or Softback (Trade Paperback (Us))
Content Language: English
More Product Details
Page Count: 64
Carton Quantity: 110
Product Dimensions: 6.00 x 0.15 x 9.00 inches
Weight: 0.23 pound(s)
Country of Origin: US
Subject Information
BISAC Categories
Medical | General
Descriptions, Reviews, Etc.
publisher marketing
Salivary gland tumors are an infrequent and heterogeneous group of neoplasms, which implies difficulties in both diagnosis and prognosis of this pathology. Ki67 is a marker that is expressed in dividing cells and has been found to be associated with increased aggressiveness in different types of tumors. The aim of this work was to demonstrate the importance of Ki67 as a prognostic factor in patients with salivary gland tumors treated with radiotherapy.Patients with localized salivary gland tumors treated with radiotherapy were evaluated; Ki67 labeling was performed by immunohistochemistry; it was stratified into high (greater than 20%), low (between 1% and 20%) and negative (less than or equal to 1%); and the expression was related to the percentage of recurrences, distant metastases and deaths due to disease.Overall survival, recurrence-free survival, metastasis-free survival and cause-specific survival were calculated. In conclusion, high Ki67 expression was associated with a higher number of metastases and deaths from disease, with worse survival in patients with salivary gland tumors.
Show More
Your Price  $51.17
Paperback